Royal Bank of Canada »

Contineum Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $19k 1.2k 15.50
2024-06-30 $15k 752 20.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Johnson & Johnson
Perceptive Advisors
Franklin Resources
Versant Venture Management
Hillhouse Capital Advisors
Samsara BioCapital
Vanguard Group
Altium Capital Management
BlackRock
BlackRock
Baker Bros. Advisors
Casdin Capital
Squarepoint Ops
Geode Capital Management

View all funds holding Contineum Therapeutics